Mark Hopman, Chief Commercial Officer at Beta Bionics, Inc. (BBNX), sold 848 shares at $18.86 ($16K) on 2025-09-02, disclosed to the SEC on 2025-09-04.
Open-market sale of $16k BBNX by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| BBNX | SELL | 2026-09-17 | $620K | — | Filing → |
| BBNX | SELL | 2026-09-15 | $12K | — | Filing → |
| BBNX | SELL | 2026-09-10 | $681K | — | Filing → |